8 Sept 2026
Epigenetic Regulation of Host Immunity During Parasitic Infections: Mechanisms, Immune Evasion, and Therapeutic OpportunitiesPublisher siteImmunological Investigations, Parasites and Host Interactions
Active, last published 2026
In covid-19 clinical research studies
Gaber El‐Saber
Batiha
Scholar“Research focused on COVID-19 Clinical Research Studies and adjacent fields.”
Damanhour University
Egypt
Claim Your ProfileEgypt70
H-index
23.5k
Citations
Gaber has not officially claimed their profile. If you are Gaber, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aber El‐Saber Batiha is a researcher working on COVID-19 Clinical Research Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Gaber's work has been cited 23,545 times across 7 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
COVID-19 Clinical Research Studies×68Essential Oils and Antimicrobial Activity×44Natural Antidiabetic Agents Studies×41Computational Drug Discovery Methods×36Long-Term Effects of COVID-19×31
04 · Where I am
Affiliations
Affiliation on published researchDamanhour University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
93 works1 Sept 2026
Activated Platelets in Multiple Sclerosis: Immunoinflammatory Mechanisms and the Therapeutic Controversy of Acetylsalicylic AcidPublisher siteMultiple Sclerosis and Related Disorders, Platelet Disorders and Treatments
8 Jul 2026
BDNF and GSK-3β signaling in depression: molecular mechanisms underlying neural plasticity dysfunctionPublisher siteMolecular Biology Reports, Nerve injury and regeneration
11 May 2026
Metformin as a multi-target modulator of atherosclerosis: integrated regulation of Nrf2/KLF2, mitochondrial homeostasis, inflammation, ferroptosis, and innate immunityPublisher siteJournal of Pharmacy and Pharmacology, Kruppel-like factors research
28 Apr 2026
Metformin as a potential therapeutic agent in broken heart syndrome: Targeting AMPK-dependent cardio-protection and microvascular functionPublisher siteMolecular Biology Reports, Takotsubo Cardiomyopathy and Associated Phenomena
16 Sept 2025
Antibacterial activity of silver nanoparticles against MDR Corynebacterium pseudotuberculosis isolated from caseous lymphadenitis casesPublisher siteMicrobial Pathogenesis, Diphtheria, Corynebacterium, and Tetanus
2 Aug 2025Open access2cites
Exploring the Multifunctional Agents of Flavonoid‐Rich Beet Leaf Extracts: Insights From Experimental and Computational StudiesPublisher siteFood Safety and Health, Cholinesterase and Neurodegenerative Diseases
6 Jun 202517cites
LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in α-synuclein and amyloid pathologyPublisher siteEuropean Journal of Pharmacology, Parkinson's Disease Mechanisms and Treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Gaber?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you